Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.

Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, Bonifacio M, Bonadonna P, Gleixner KV, Hadzijusufovic E, Perkins C, Hartmann K, Illerhaus A, Merante S, Elena C, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, David Fuchs, Greul R, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Al-Ali HK, Morren MA, Varkonyi J, Zink A, Niedoszytko M, Niederwieser D, Malcovati L, Reiter A, Kennedy V, Gotlib J, Lortholary O, Hermine O, Arock M, Kluin-Nelemans H, Sperr WR; Study Group of the European Competence Network on Mastocytosis (ECNM).

J Allergy Clin Immunol Pract. 2018 Nov 8. pii: S2213-2198(18)30601-9. doi: 10.1016/j.jaip.2018.09.024. [Epub ahead of print] Review.

PMID:
30416055
2.

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.

Baliakas P, Moysiadis T, Hadzidimitriou A, Xochelli A, Jeromin S, Agathangelidis A, Mattsson M, Sutton LA, Minga E, Scarfò L, Rossi D, Davis Z, Villamor N, Parker H, Kotaskova J, Stalika E, Plevova K, Mansouri L, Cortese D, Navarro A, Delgado J, Larrayoz M, Young E, Anagnostopoulos A, Smedby KE, Juliusson G, Sheehy O, Catherwood M, Strefford JC, Stavroyianni N, Belessi C, Pospisilova S, Oscier D, Gaidano G, Campo E, Haferlach C, Ghia P, Rosenquist R, Stamatopoulos K.

Haematologica. 2018 Sep 27. pii: haematol.2018.195032. doi: 10.3324/haematol.2018.195032. [Epub ahead of print]

3.

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.

Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg UC, Jansson B, Persson N, Emruli VK, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I, Mattsson M.

NPJ Precis Oncol. 2018 Sep 3;2:18. doi: 10.1038/s41698-018-0061-2. eCollection 2018.

4.

Editorial: Effects of Combined EMF Exposures and Co-exposures.

Mattsson MO, Zeni O, Simkó M, Scarfì MR.

Front Public Health. 2018 Aug 20;6:230. doi: 10.3389/fpubh.2018.00230. eCollection 2018. No abstract available.

5.

Serological reactivity to Anaplasma phagocytophilum in neoehrlichiosis patients.

Wass L, Grankvist A, Mattsson M, Gustafsson H, Krogfelt K, Olsen B, Nilsson K, Mårtensson A, Quarsten H, Henningsson AJ, Wennerås C.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1673-1678. doi: 10.1007/s10096-018-3298-3. Epub 2018 Jun 14.

6.

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.

Primo D, Scarfò L, Xochelli A, Mattsson M, Ranghetti P, Espinosa AB, Robles A, Gorrochategui J, Martínez-López J, de la Serna J, González M, Gil AC, Anguita E, Iraheta S, Munugalavadla V, Quéva C, Tannheimer S, Rosenquist R, Stamatopoulos K, Ballesteros J, Ghia P.

Oncotarget. 2018 May 25;9(40):26019-26031. doi: 10.18632/oncotarget.25419. eCollection 2018 May 25.

7.

Association of Hypertensive Disorders of Pregnancy With Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis.

Maher GM, O'Keeffe GW, Kearney PM, Kenny LC, Dinan TG, Mattsson M, Khashan AS.

JAMA Psychiatry. 2018 Aug 1;75(8):809-819. doi: 10.1001/jamapsychiatry.2018.0854.

PMID:
29874359
8.

Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity.

Rosado MM, Simkó M, Mattsson MO, Pioli C.

Front Public Health. 2018 Mar 26;6:85. doi: 10.3389/fpubh.2018.00085. eCollection 2018. Review.

9.

Consensus on core phenomena and statements describing Basic Body Awareness Therapy within the movement awareness domain in physiotherapy.

Skjaerven LH, Mattsson M, Catalan-Matamoros D, Parker A, Gard G, Gyllensten AL.

Physiother Theory Pract. 2018 Feb 26:1-14. doi: 10.1080/09593985.2018.1434578. [Epub ahead of print]

PMID:
29482403
10.

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton LA, Scarfo L, Davis Z, Yan XJ, Plevova K, Sandberg Y, Vojdeman FJ, Tzenou T, Chu CC, Veronese S, Mansouri L, Smedby KE, Giudicelli V, Nguyen-Khac F, Panagiotidis P, Juliusson G, Anagnostopoulos A, Lefranc MP, Trentin L, Catherwood M, Montillo M, Niemann CU, Langerak AW, Pospisilova S, Stavroyianni N, Chiorazzi N, Oscier D, Jelinek DF, Shanafelt T, Darzentas N, Belessi C, Davi F, Ghia P, Rosenquist R, Stamatopoulos K.

Haematologica. 2018 Apr;103(4):e158-e161. doi: 10.3324/haematol.2017.182634. Epub 2017 Dec 21. No abstract available.

11.

Cellular Response to ELF-MF and Heat: Evidence for a Common Involvement of Heat Shock Proteins?

Zeni O, Simkó M, Scarfi MR, Mattsson MO.

Front Public Health. 2017 Oct 18;5:280. doi: 10.3389/fpubh.2017.00280. eCollection 2017. Review.

12.

Natural IgM antibodies in the immune defence against neoehrlichiosis.

Wennerås C, Goldblatt D, Zancolli M, Mattsson M, Wass L, Hörkkö S, Rosén A.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):809-816. doi: 10.1080/23744235.2017.1347815. Epub 2017 Jul 6.

PMID:
28682152
13.

Identification of Host Fruit Volatiles from Snowberry (Symphoricarpos albus), Attractive to Rhagoletis zephyria Flies from the Western United States.

Cha DH, Olsson SB, Yee WL, Goughnour RB, Hood GR, Mattsson M, Schwarz D, Feder JL, Linn CE Jr.

J Chem Ecol. 2017 Feb;43(2):188-197. doi: 10.1007/s10886-016-0814-8. Epub 2017 Jan 11.

PMID:
28078623
14.

The changing face of nanomaterials: Risk assessment challenges along the value chain.

Mattsson MO, Simkó M.

Regul Toxicol Pharmacol. 2017 Mar;84:105-115. doi: 10.1016/j.yrtph.2016.12.008. Epub 2016 Dec 18. Review.

PMID:
27998719
15.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2016 Jun;5(6):845. doi: 10.5966/sctm.2015-0021erratum. No abstract available.

16.

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.

Winqvist M, Asklid A, Andersson PO, Karlsson K, Karlsson C, Lauri B, Lundin J, Mattsson M, Norin S, Sandstedt A, Hansson L, Österborg A.

Haematologica. 2016 Dec;101(12):1573-1580. Epub 2016 May 19.

17.

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2.

Bhoi S, Ljungström V, Baliakas P, Mattsson M, Smedby KE, Juliusson G, Rosenquist R, Mansouri L.

Epigenetics. 2016 Jun 2;11(6):449-55. doi: 10.1080/15592294.2016.1178432. Epub 2016 Apr 29.

18.
19.

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Baliakas P, Mattsson M, Stamatopoulos K, Rosenquist R.

J Intern Med. 2016 Apr;279(4):347-57. doi: 10.1111/joim.12455. Epub 2015 Dec 28. Review.

20.

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi S, Baliakas P, Cortese D, Mattsson M, Engvall M, Smedby KE, Juliusson G, Sutton LA, Mansouri L.

Haematologica. 2016 Feb;101(2):e63-5. doi: 10.3324/haematol.2015.136440. Epub 2015 Nov 20. No abstract available.

21.

Pooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.

Simkó M, Tischler S, Mattsson MO.

Int J Mol Sci. 2015 Nov 2;16(11):26211-36. doi: 10.3390/ijms161125954.

22.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2015 Oct;4(10):1199-213. doi: 10.5966/sctm.2015-0021. Epub 2015 Aug 18. Erratum in: Stem Cells Transl Med. 2016 Jun;5(6):845.

23.

A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice.

Otto C, Särnefält A, Ljungars A, Wolf S, Rohde-Schulz B, Fuchs I, Schkoldow J, Mattsson M, Vonk R, Harrenga A, Freiberg C.

Endocrinology. 2015 Nov;156(11):4365-73. doi: 10.1210/en.2015-1277. Epub 2015 Aug 18.

PMID:
26284426
24.

The impact of hypnotic suggestions on reaction times in continuous performance test in adults with ADHD and healthy controls.

Virta M, Hiltunen S, Mattsson M, Kallio S.

PLoS One. 2015 May 11;10(5):e0126497. doi: 10.1371/journal.pone.0126497. eCollection 2015.

25.

Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference.

Dür M, Coenen M, Stoffer MA, Fialka-Moser V, Kautzky-Willer A, Kjeken I, Drăgoi RG, Mattsson M, Boström C, Smolen J, Stamm TA.

Health Qual Life Outcomes. 2015 Feb 25;13:27. doi: 10.1186/s12955-015-0214-8.

26.

Measurement invariance of the Driver Behavior Questionnaire across samples of young drivers from Finland and Ireland.

Mattsson M, O'Brien F, Lajunen T, Gormley M, Summala H.

Accid Anal Prev. 2015 May;78:185-200. doi: 10.1016/j.aap.2015.02.017. Epub 2015 Mar 19.

PMID:
25797304
27.

Depth, soil type, water table, and site effects on microbial community composition in sediments of pesticide-contaminated aquifer.

Mattsson MK, Liu X, Yu D, Kontro MH.

Environ Sci Pollut Res Int. 2015 Jul;22(13):10263-79. doi: 10.1007/s11356-015-4224-1. Epub 2015 Feb 24.

PMID:
25703619
28.

Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures. A multicentre European qualitative study and literature review.

Mattsson M, Boström C, Mihai C, Stöcker J, Geyh S, Stummvoll G, Gard G, Möller B, Hesselstrand R, Sandqvist G, Draghicescu O, Gherghe AM, Voicu M, Distler O, Smolen JS, Stamm TA.

Eur J Phys Rehabil Med. 2015 Aug;51(4):405-21. Epub 2015 Jan 9. Review.

29.
30.

[Danish studies of acute treatment after initiation of emergency departments].

Mattsson MS, Jørsboe H.

Ugeskr Laeger. 2014 Jul 21;176(30):1396-8. Review. Danish.

PMID:
25292231
31.
32.

EMF monitoring-concepts, activities, gaps and options.

Dürrenberger G, Fröhlich J, Röösli M, Mattsson MO.

Int J Environ Res Public Health. 2014 Sep 11;11(9):9460-79. doi: 10.3390/ijerph110909460. Review.

33.

Interactions between nanosized materials and the brain.

Simkó M, Mattsson MO.

Curr Med Chem. 2014;21(37):4200-14. Review.

34.

Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases.

Grankvist A, Andersson PO, Mattsson M, Sender M, Vaht K, Höper L, Sakiniene E, Trysberg E, Stenson M, Fehr J, Pekova S, Bogdan C, Bloemberg G, Wennerås C.

Clin Infect Dis. 2014 Jun;58(12):1716-22. doi: 10.1093/cid/ciu189. Epub 2014 Mar 18.

35.

Dietary nitrate reduces resting metabolic rate: a randomized, crossover study in humans.

Larsen FJ, Schiffer TA, Ekblom B, Mattsson MP, Checa A, Wheelock CE, Nyström T, Lundberg JO, Weitzberg E.

Am J Clin Nutr. 2014 Apr;99(4):843-50. doi: 10.3945/ajcn.113.079491. Epub 2014 Feb 5.

PMID:
24500154
36.

On testing factorial invariance: A reply to J.C.F. de Winter.

Mattsson M.

Accid Anal Prev. 2014 Feb;63:89-93. doi: 10.1016/j.aap.2013.10.031. Epub 2013 Nov 2.

PMID:
24275719
37.

Is there a relation between extremely low frequency magnetic field exposure, inflammation and neurodegenerative diseases? A review of in vivo and in vitro experimental evidence.

Mattsson MO, Simkó M.

Toxicology. 2012 Nov 15;301(1-3):1-12. doi: 10.1016/j.tox.2012.06.011. Epub 2012 Jun 29. Review.

PMID:
22750629
38.

Investigating the factorial invariance of the 28-item DBQ across genders and age groups: an Exploratory Structural Equation Modeling study.

Mattsson M.

Accid Anal Prev. 2012 Sep;48:379-96. doi: 10.1016/j.aap.2012.02.009. Epub 2012 Mar 8.

PMID:
22664704
39.

Psychometric evaluation of the Danish and Swedish Satisfaction with Life Scale in first episode psychosis patients.

Hochwälder J, Mattsson M, Holmqvist R, Cullberg J, Rosenbaum B.

Qual Life Res. 2013 Apr;22(3):537-46. doi: 10.1007/s11136-012-0185-8. Epub 2012 May 15.

PMID:
22585189
40.

A field test for host fruit odour discrimination and avoidance behaviour for Rhagoletis pomonella flies in the western United States.

Sim SB, Mattsson M, Feder JL, Cha DH, Yee WL, Goughnour RB, Linn CE Jr, Feder JL.

J Evol Biol. 2012 May;25(5):961-71. doi: 10.1111/j.1420-9101.2012.02489.x. Epub 2012 Mar 21.

41.

Uncertainty and opportunities in patients with established systemic lupus erythematosus: a qualitative study.

Mattsson M, Möller B, Stamm T, Gard G, Boström C.

Musculoskeletal Care. 2012 Mar;10(1):1-12. doi: 10.1002/msc.220. Epub 2011 Oct 18.

PMID:
22009870
42.

Proteomic analysis and discovery using affinity proteomics and mass spectrometry.

Olsson N, Wingren C, Mattsson M, James P, O'Connell D, Nilsson F, Cahill DJ, Borrebaeck CA.

Mol Cell Proteomics. 2011 Oct;10(10):M110.003962. doi: 10.1074/mcp.M110.003962. Epub 2011 Jun 14.

43.

Comparing mixing and displacement ventilation in classrooms: pupils' perception and health.

Smedje G, Mattsson M, Wålinder R.

Indoor Air. 2011 Dec;21(6):454-61. doi: 10.1111/j.1600-0668.2011.00725.x. Epub 2011 Jun 28.

PMID:
21615502
44.

Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries.

Stamm TA, Mattsson M, Mihai C, Stöcker J, Binder A, Bauernfeind B, Stummvoll G, Gard G, Hesselstrand R, Sandqvist G, Draghicescu O, Gherghe AM, Voicu M, Machold KP, Distler O, Smolen JS, Boström C.

Ann Rheum Dis. 2011 Jun;70(6):1074-9. doi: 10.1136/ard.2010.148767.

45.

Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review.

Simkó M, Mattsson MO.

Part Fibre Toxicol. 2010 Dec 21;7:42. doi: 10.1186/1743-8977-7-42. Review.

46.

ELF noise fields: a review.

Mild KH, Mattsson MO.

Electromagn Biol Med. 2010 Aug;29(3):72-97. doi: 10.3109/15368378.2010.482487. Review.

PMID:
20707642
47.

Effects of 50-Hz magnetic field exposure on superoxide radical anion formation and HSP70 induction in human K562 cells.

Mannerling AC, Simkó M, Mild KH, Mattsson MO.

Radiat Environ Biophys. 2010 Nov;49(4):731-41. doi: 10.1007/s00411-010-0306-0. Epub 2010 Jun 26.

PMID:
20582429
48.

With power comes responsibility: motorcycle engine power and power-to-weight ratio in relation to accident risk.

Mattsson M, Summala H.

Traffic Inj Prev. 2010 Feb;11(1):87-95. doi: 10.1080/15389580903471126.

PMID:
20146148
49.

Exposure to ELF magnetic fields modulate redox related protein expression in mouse macrophages.

Frahm J, Mattsson MO, Simkó M.

Toxicol Lett. 2010 Feb 15;192(3):330-6. doi: 10.1016/j.toxlet.2009.11.010. Epub 2009 Nov 12.

PMID:
19913603
50.

Background ELF magnetic fields in incubators: a factor of importance in cell culture work.

Mild KH, Wilén J, Mattsson MO, Simko M.

Cell Biol Int. 2009 Jul;33(7):755-7. doi: 10.1016/j.cellbi.2009.04.004. Epub 2009 Apr 23.

PMID:
19393752

Supplemental Content

Loading ...
Support Center